atropine and pralidoxime chloride

FDA Drug Profile — DuoDote, ATNAA atropine and pralidoxime chloride Auto-Injector

Drug Details

Generic Name
atropine and pralidoxime chloride
Brand Names
DuoDote, ATNAA atropine and pralidoxime chloride Auto-Injector
Application Number
NDA021983
Sponsor
Meridian Medical Technologies LLC
NDC Codes
2
Dosage Forms
KIT
Routes
INTRAMUSCULAR
Active Ingredients
N/A

Indications and Usage

1 INDICATIONS AND USAGE ATNAA is indicated for the treatment of poisoning by susceptible organophosphorus nerve agents having anticholinesterase activity in adults. ATNAA, a combination of atropine, a cholinergic muscarinic antagonist, and pralidoxime chloride, a cholinesterase reactivator, is indicated for the treatment of poisoning by susceptible organophosphorus nerve agents having anticholinesterase activity in adults. ( 1 )